C14 and P8 also significantly decreased K-Ras4B activation and signaling pathways in primary PDAC cell cultures without affecting nonmalignant mesenchymal or fibroblast-like primary cultures, thus confirming their specificity toward pancreatic cancer cells. This evidence concerns the gene KRAS and pancreatic neoplasm.